About this item:

333 Views | 363 Downloads

Author Notes:

Corresponding Author: Sunil Singhal, M.D., Assistant Professor, University of Pennsylvania School of Medicine, 6 White Building, 3400 Spruce Street, Philadelphia, PA 19104. sunil.singhal@uphs.upenn.edu

The authors would like to acknowledge Dr. Steven M. Albelda for his valuable input in experimental design and manuscript review.

Disclosures: One of the authors (SN) is a consultant of SpectroPath, Inc., a startup company in Atlanta,GA to develop advanced instrumentation and nanoparticle contrast agents for image-guided surgery.

Subjects:

Research Funding:

This work was supported by the National Institutes of Health Grand Opportunities Grant RC2CA148265 (M.W., S.N., S.S.) & Society of Surgical Oncology Clinical Scholar Award (S.S.) & American Kennel Club Acorn Grant (D.H., S.S.).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Oncology
  • ENHANCED PERMEABILITY
  • INDOCYANINE GREEN
  • BREAST BIOPSIES
  • SURGERY
  • CANCER
  • LUMPECTOMY
  • RETENTION
  • ONCOLOGY
  • MARGINS
  • MODEL
  • Intraoperative imaging
  • Surgical oncology
  • Infrared
  • Margins
  • Indocyanine green

Intraoperative Near-Infrared Imaging of Surgical Wounds after Tumor Resections Can Detect Residual Disease

Tools:

Journal Title:

Clinical Cancer Research

Volume:

Volume 18, Number 20

Publisher:

, Pages 5741-5751

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Purpose: Surgical resection remains the most effective therapy for solid tumors worldwide. The most important prognostic indicator for cure following cancer surgery is a complete resection with no residual disease. However, intraoperative detection of retained cancer cells after surgery is challenging, and residual disease continues to be the most common cause of local failure. We hypothesized that visual enhancement of tumors using near-infrared imaging could potentially identify tumor deposits in the wound after resection. Experimental Design: A small animal model of surgery and retained disease was developed. Residual tumor deposits in the wound were targeted using an U.S. Food and Drug Administration-approved imaging agent, indocyanine green, by the enhanced permeability and retention effect. A novel handheld spectrometer was used to optically visualize retained disease after surgery. Results: We found residual disease using near-infrared imaging during surgery that was not visible to the naked eye or micro-CT. Furthermore, examination of tumor nodules was remarkably precise in delineating margins from normal surrounding tissues. This approach was most successful for tumors with increased neovasculature. Conclusions: The results suggest that near-infrared examination of the surgical wound after curative resection can potentially enable the surgeon to locate residual disease. The data in this study is the basis of an ongoing Phase I/II clinical trial in patients who undergo resection for lung and breast cancer.

Copyright information:

©2012 AACR.

Export to EndNote